Keyphrases
Patient Survival
100%
Diabetes
100%
Multiple Myeloma
100%
Racial Groups
100%
Type 1 Diabetes Mellitus (T1DM)
87%
Black Men
62%
RAG1
50%
Overall Survival
37%
MKR Mice
37%
Mouse Model
25%
Xenograft
25%
Hazard Ratio
12%
Obesity
12%
Arginine
12%
Confidence Interval
12%
White Patients
12%
Cox Model
12%
Multivariable
12%
Tumor Growth
12%
High Incidence
12%
White People
12%
Racial Differences
12%
Western Blot Analysis
12%
Genetic Engineering
12%
Insulin-like Growth Factor 1 Receptor (IGF1R)
12%
Patients with Diabetes Mellitus
12%
Lysine
12%
MM.1S
12%
Retrospective Clinical Study
12%
Creatinine Kinase
12%
Mammalian Target of Rapamycin Pathway
12%
Non-obese Diabetic
12%
S6 Ribosomal Protein
12%
Promoter Expression
12%
Diabetes Mellitus Management
12%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Overall Survival
100%
Promoter Region
33%
Tumor Progression
33%
Race Difference
33%
Mouse Model
33%
Clinical Study
33%
Mechanistic Target of Rapamycin
33%
Creatine Kinase
33%
Ribosomal Protein S6
33%
Arginine
33%
Western Blotting
33%
Lysine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Diabetes Mellitus
100%
Multiple Myeloma
100%
Overall Survival
30%
Western Blot
10%
Tumor Growth
10%
Mouse Model
10%
Clinical Study
10%
Creatine Kinase
10%
Arginine
10%
Lysine
10%
Mammalian Target of Rapamycin
10%
Protein S6
10%
Immunology and Microbiology
Multiple Myeloma
100%
Prevalence
100%
Overall Survival
37%
Xenograft
25%
Promoter Region
12%
Western Blot
12%
Race Difference
12%
Mouse Model
12%
Sirolimus
12%